-
NuVasive (NUVA) PT Lowered to $65 at RBC Capital
-
RBC Recommends Taking Profits in NuVasive (NUVA) on Deal Talk
-
RBC Capital Remains Bullish on NuVasive (NUVA) Following CEO Transition
-
NuVasive (NUVA) PT Lowered to $65 at RBC Capital; 'Profitability Below Expectations'
-
Notable Analyst Rating Changes 4/15: (GPRO) (DFS) (EVEP) Upgraded; (BLDR) (MPEL) (FMSA) Downgraded
-
RBC Capital Upgrades NuVasive (NUVA) to Outperform
-
Notable Analyst Rating Changes 02/27: (MDRX) (NOK) (RSH) Upgraded; (GTI) (FSLR) (NUVA) Downgraded
-
RBC Capital Upgrades NuVasive (NUVA) to Sector Perform
-
Notable Analyst Rating Changes 10/04: (EBAY) (AMD) (EIX) Upgraded; (S) (NUVA) (PCS) Downgraded
-
RBC Capital Downgrades NuVasive (NUVA) to Underperform
-
RBC Capital Upgrades NuVasive (NUVA) to Outperform
-
Notable Analyst Rating Changes 10/29: MWW, VVUS, MS, LVS Upgraded; FSLR, MEOH, NUVA, AVP Downgraded

